Special Advertising Section

Outpatient Surgery Logo
Outpatient Surgery Logo

These Ophthalmic Formulations Improve Outcomes and Cut Costs

Improve ophthalmic surgery outcomes and patient compliance and reduce costs with compounded formulations from Imprimis Pharmaceuticals. Your surgeons can inject "Dropless" steroid-antibiotic combinations intraocularly after implanting the IOL, obviating the need for drops. Alternatively, give patients "LessDrops," a topical formulation with your choice of a combination of a steroid, a non-steroidal, and an antibiotic. Now a 503B FDA-registered outsourcing facility, Imprimis makes ordering easy. Expect a fast turnaround, no need for individual prescriptions and free shipping on all 503B orders.

For more information, call (844) 446-6979, visit www.imprimisrx.com/order503B or click on "Learn More" below.

Related Products

Visit Facebook Visit Twitter

To receive information regarding "Imprimis Pharmaceuticals compounded formulations ophthalmic surgery Dropless LessDrops 503B," please enter your contact information below:

You can also Log In to have some of this information filled in for you

First name:
Last name:
Degree: (MD, RSN, etc.)
Facility name:
Professional title:
ZIP code:
Email address:

Thank you!

Your product information request has been received and we will forward information to the contact information you provided shortly.